A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

Clinical trial NCT03574584 · COMPLETED

Trial details

NCT number: NCT03574584
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metabolism and Nutrition Disorders Overweight or Obesity

Start date: 2018-06-18
Primary completion: 2019-07-27
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.